Kodiak Sciences (KOD) Capital Expenditures (2017 - 2026)
Kodiak Sciences (KOD) reported Capital Expenditures of $942000.0 for Q1 2026, up 248.89% on a YoY basis from $270000.0 in Q1 2025, and up 2090.7% quarter-over-quarter from $43000.0 in Q4 2025.
Kodiak Sciences (KOD) Capital Expenditures (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Capital Expenditures for 10 years, with the latest figure at $942000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 248.89% year-over-year to $942000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (up 89.09% YoY), and the FY2025 full-year result was $506000.0, up 34.93% from the prior year.
- Capital Expenditures for Q1 2026 stood at $942000.0, up from $43000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $27.5 million in Q4 2023, with the low at $22000.0 in Q1 2024.
- Historically, Capital Expenditures has averaged $4.7 million across 5 years, with a median of $270000.0 in 2025.
- Annual changes were most pronounced in 2022 — Capital Expenditures soared 1311.48% — and 2024, when it sank 99.82%.
- Kodiak Sciences' Capital Expenditures stood at $3.1 million in 2022, then soared by 797.29% to $27.5 million in 2023, then plunged by 99.55% to $124000.0 in 2024, then plunged by 65.32% to $43000.0 in 2025, then soared by 2090.7% to $942000.0 in 2026.
- The last three Capital Expenditures figures came in at $942000.0 (Q1 2026), $43000.0 (Q4 2025), and $60000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -63,220.27 |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 942,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 942,000.00 |
| Mar 31, 2026 | 942,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Jun 30, 2025 | 133,000.00 |
| Mar 31, 2025 | 270,000.00 |
| Mar 31, 2025 | 270,000.00 |
| Dec 31, 2024 | 124,000.00 |
| Dec 31, 2024 | 124,000.00 |
| Sep 30, 2024 | 180,000.00 |
| Sep 30, 2024 | 180,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 27.48 Mn |
| Dec 31, 2023 | 27.48 Mn |